Outcome | n | % | Risk ratio (ITT) | p value | 95% CI | |
---|---|---|---|---|---|---|
Unadjusted (n = 77) | Adjusteda (n = 77) | |||||
Intention-to-treat analysis (ITT): non-adherence to first clinic visit, re-admission over 9Â months | ||||||
 Non-adherence to first clinic appointment | ||||||
  Intervention (n = 42) | 14 | 33.3 | 0.72 | 0.79 | 0.419 | 0.44 to 1.39 |
  Treatment as usual (n = 35) | 16 | 45.7 | – | – | – | – |
 Any re-admission over 9 months | ||||||
  Intervention (n = 42) | 5 | 11.9 | 0.83 | 0.86 | 0.713 | 0.39 to 1.87 |
  Treatment as usual (n = 35) | 5 | 14.3 | – | – | – | – |
Outcome | Complete case analysisc (intervention vs. TAU) | ITT (intervention vs. TAU) | ||||||
---|---|---|---|---|---|---|---|---|
Mean differenced | p value | 95% CI | Mean differencee (n = 77) | p value | 95% CI | |||
Unadjusted | Adjusted | Unadjusted | Adjusted | |||||
Complete case and intention to treat analysis (ITT) of other efficacy outcomes at 3Â months | ||||||||
 PANSS score | ||||||||
  Total score | − 9.4 | − 14.7 | 0.052 | − 29.71 to 0.16 | − 13.4 | − 13.1 | 0.062 | − 27.00 to 0.73 |
  Positive subscale | − 3.8 | − 6.4 | 0.011 | − 11.20 to 1.60 | − 5.6 | − 5.4 | 0.060 | − 11.16 to 0.25 |
  Negative subscale | − 2.6 | −4.4 | 0.059 | − 8.99 to 0.18 | − 3.5 | − 3.5 | 0.078 | − 7.52 to 0.43 |
  General subscale | − 2.8 | − 3.9 | 0.350 | − 12.6 1 to 4.68 | − 4.4 | − 4.2 | 0.248 | − 11.67 to 3.19 |
 MARS | − 0.21 | − 0.75 | 0.425 | − 2.68 to 1.17 | 0.36 | 0.49 | 0.603 | − 1.44 to 2.43 |
 CGI | − 0.8 | − 0.58 | 0.346 | − 1.84 to 0.67 | – | – | – | – |
 GAF | 7.5 | 4.1 | 0.440 | − 6.90 to 15.17 | – | – | – | – |
 CAN |  |  |  |  | – | – | – | – |
  Total needs | – | – | – | – | – | – | – | – |
  Unmet needs | − 3.2 | − 3.6 | 0.029 | − 6.74 to 0.49 | – | – | – | – |
  Met needs | – | – | – | – | – | – | – | – |
EUROQUEL-VAS | 16.1 | 15.2 | 0.124 | − 4.59 to 34.99 | – | – | – | – |